Evidence map›Paper›PMID 36124123›Full record

ArticleJHEP reports : innovation in hepatology2022

Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigen.

Bingqian Qu, Firat Nebioglu, Mila M Leuthold, Yi Ni, Pascal Mutz, Jürgen Beneke, Holger Erfle, Florian W R Vondran, Ralf Bartenschlager, Stephan Urban

Open access · goldAbstract read
In one paragraph

Article in JHEP reports : innovation in hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Bingqian QuDepartment of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
Firat NebiogluDepartment of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
Mila M LeutholdDepartment of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
Yi NiDepartment of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
Pascal MutzDepartment of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
Jürgen BenekeAdvanced Biological Screening Facility Center for Quantitative Analysis of Molecular and Cellular Biosystems (BioQuant), Heidelberg University, Heidelberg, Germany.
Holger ErfleAdvanced Biological Screening Facility Center for Quantitative Analysis of Molecular and Cellular Biosystems (BioQuant), Heidelberg University, Heidelberg, Germany.
Florian W R VondranGerman Center for Infection Research (DZIF), Hannover-Braunschweig Partner site, Hannover, Germany.
Ralf BartenschlagerDepartment of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
Stephan UrbanDepartment of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
Heidelberg University · DEGerman Cancer Research Center · DEMedizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Aims: HBV persistence is maintained by both an episomal covalently closed circular (ccc)DNA reservoir and genomic integration of HBV DNA fragments. While cccDNA transcription is regulated by Cullin4A-DDB1-HBx-mediated degradation of the SMC5/6 complex, HBsAg expression from integrants is largely SMC5/6 independent. Inhibiting neddylation of Cullin-RING ubiquitin ligases impairs degradation of substrates. Herein, we show that targeting neddylation pathway components by small-interfering (si)RNAs or the drug MLN4924 (pevonedistat) suppresses expression of HBV proteins from both cccDNA and integrants. Methods: An siRNA screen targeting secretory pathway regulators and neddylation genes was performed. Activity of MLN4924 was assessed in infection and integration models. Trans-complementation assays were used to study HBx function in cccDNA-driven expression. Results: siRNA screening uncovered neddylation pathway components ( Conclusions: Neddylation is required both for transcription of a cccDNA reservoir and for the genomic integration of viral DNA. Therefore, blocking neddylation might offer an attractive approach towards functional cure of chronic hepatitis B. Lay summary: Current treatments for chronic hepatitis B are rarely able to induce a functional cure. This is partly because of the presence of a pool of circular viral DNA in the host nucleus, as well as viral DNA fragments that are integrated into the host genome. Herein, we show that a host biological pathway called neddylation could play a key role in infection and viral DNA integration. Inhibiting this pathway could hold therapeutic promise for patients with chronic hepatitis B.

Indexed as

cccDNAcccDNA, covalently closed circular DNADDB1, DNA damage-binding protein 1HBsAgHBsAg, hepatitis B virus surface antigenHBxHBx, hepatitis B virus X proteinintegrantsMLN4924NAE1, NEDD8-activating enzyme E1 subunit 1NEDD8, neural precursor cell expressed, developmentally downregulated 8neddylationpgRNA, pregenomic RNAPHHs, primary human hepatocytessiRNA, small-interfering RNASmc5/6, structural maintenance of chromosomes 5/6SMC6SVP, subviral particlestranscriptionWT, wild-type

Identifiers

PMID36124123
PMCPMC9482114
OpenAlexW4290462446

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.